Pharmacy World & Science · 2007 · 25 citations · 12 references
MedicineHematologyPharmacoeconomicsCost-effectiveness AnalysisCost-utility AnalysisTransfusion MedicineBleeding DisordersClinical HematologyHealthcare Cost AnalysisHemolytic DisordersHemostatic DisordersAdult Hemophilia CareDisease Cost Of IllnessFactor Viii ReplacementHigh-cost Illness Impact
12
Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
S. Ehrenforth, W. Kreuz, R. Linde et al. · The Lancet · 1992 · 608 citations
Medicine, Hematology, Hemostasis +11
Epidemiological survey of the orthopaedic status of severe haemophilia A and B patients in France
Molho, Rolland, Lebrun et al. · Haemophilia · 2000 · 175 citations
Clinical outcomes and resource utilization associated with haemophilia care in Europe
W. Schramm, Scott Royal, Barbara L. Kroner et al. · Haemophilia · 2002 · 109 citations · Full text
The natural history of factor VIII inhibitors in patients with hemophilia A.